tiprankstipranks
Epigenomics (GB:0QXH)
LSE:0QXH

Epigenomics (0QXH) Revenue

0 Followers

Epigenomics Revenue

Epigenomics had a revenue of ― in the quarter ending ―, with ―. This bring the company's revenue in the last twelve months to ―, Decreased ―. In the fiscal year ending Dec 31, 2023, Epigenomics had annual revenue of 339.00K with -30.10% growth.
Revenue (ttm)
Revenue Growth
P/S Ratio
2.38
Revenue/Employee
€339,000
Employees
1
Market Cap
€806.79K

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2023
339.00K-146.00K-30.10%
Mar 31, 2023
485.00K-5.72M-92.18%
Dec 31, 2021
6.20M